3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Colorectal Neoplasms
7
Breast Neoplasms
5
Thyroid Neoplasms
2
Stomach Neoplasms
2
Recurrence
2
Prostatic Neoplasms
2
Pilonidal Sinus
2
Neuroma
2
Neuralgia
2
Neoplasm Metastasis
2
Head and Neck Neoplasms
2
Chronic Pain
2
Uterine Cervical Neoplasms
1
Urologic Neoplasms
1
Recurrent Laryngeal Nerve Injuries
1
Prostate Biopsy
1
Peripheral Nervous System Diseases
1
Pain, Postoperative
1
Pain, Intractable
1
Ovarian Cysts
1
Oropharyngeal Neoplasms
1
Nevus, Pigmented
1
Nerve Block
1
Neoplasms
1
Melanoma
1
Lung Neoplasms
1
Localised Prostate Cancer
1
Liver Neoplasms
1
Invasive Bladder Cancer
1
Intracranial Aneurysm
1
Interventions
Sodium Chloride
1
Lidocaine
1
Hyperthermic Intraperitoneal Chemotherapy
1
Cystectomy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Invasive Bladder Cancer
×
Lidocaine
×
Clear all
NCT02924480
2022-03-09
Lidocaine
CAMC Health System
Phase NA
Completed
50 enrolled